TCT 870: Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker’s Bureau - Abbott Vascular; Abiomed; Boston Scientific Corporation; CARANX Medical; Cardiovascular System Inc; Edwards Lifesciences; Egnite; Medtronic; Opsens; Shockwave; Teleflex; 4C Medical
- Equity/Stock(s)/Options - Pi-cardia; Puzzle Medical; Soundbite Medical Inc